• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估连续性肾脏替代治疗期间规定的与实现的液体平衡与死亡率结局。

Assessment of prescribed vs. achieved fluid balance during continuous renal replacement therapy and mortality outcome.

机构信息

Division of Nephrology, Department of Internal Medicine, Bone and Mineral Metabolism, University of Kentucky, Lexington, Kentucky, United States of America.

Division of Nephrology, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.

出版信息

PLoS One. 2022 Aug 25;17(8):e0272913. doi: 10.1371/journal.pone.0272913. eCollection 2022.

DOI:10.1371/journal.pone.0272913
PMID:36006963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9409548/
Abstract

BACKGROUND

Fluid management during continuous renal replacement therapy (CRRT) requires accuracy in the prescription of desired patient fluid balance (FBGoal) and precision in the attainable patient fluid balance (FBAchieved). Herein, we examined the association of the gap between prescribed vs. achieved patient fluid balance during CRRT (%FBGap) with hospital mortality in critically ill patients.

METHODS

Cohort study of critically ill adults with acute kidney injury (AKI) requiring CRRT and a prescription of negative fluid balance (mean patient fluid balance goal of negative ≥0.5 liters per day). Fluid management parameters included: 1) NUF (net ultrafiltration rate); 2) FBGoal; 3) FBAchieved; and 4) FBGap (% gap of fluid balance achieved vs. goal), all adjusted by patient's weight (kg) and duration of CRRT (hours).

RESULTS

Data from 653 patients (median of 102.2 patient-hours of CRRT) were analyzed. Mean (SD) age was 56.7 (14.6) years and 61.9% were male. Hospital mortality rate was 64%. Despite FBGoal was similar in patients who died vs. survived, survivors achieved greater negative fluid balance during CRRT than non-survivors: median FBAchieved -0.25 [-0.52 to -0.05] vs. 0.06 [-0.26 to 0.62] ml/kg/h, p<0.001. Median NUF was lower in patients who died vs. survived: 1.06 [0.63-1.47] vs. 1.22 [0.82-1.69] ml/kg/h, p<0.001, and median %FBGap was higher in patients who died (112.8%, 61.5 to 165.7) vs. survived (64.2%, 30.5 to 91.8), p<0.001. In multivariable models, higher %FBGap was independently associated with increased risk of hospital mortality: aOR (95% CI) 1.01 (1.01-1.02), p<0.001. NUF was not associated with hospital mortality when adjusted by %FBGap and other clinical parameters: aOR 0.96 (0.72-1.28), p = 0.771.

CONCLUSIONS

Higher %FBGap was independently associated with an increased risk of hospital mortality in critically ill adults with AKI on CRRT in whom clinicians prescribed negative fluid balance via CRRT. %FBGap represents a novel quality indicator of CRRT delivery that could assist with operationalizing fluid management interventions during CRRT.

摘要

背景

连续性肾脏替代治疗(CRRT)期间的液体管理需要准确地规定所需的患者液体平衡(FBGoal)和精确地实现患者液体平衡(FBAchieved)。在此,我们研究了 CRRT 期间规定的与实现的患者液体平衡之间的差距(%FBGap)与危重症患者住院死亡率之间的关联。

方法

这是一项对需要 CRRT 且处方为负液体平衡(平均患者液体平衡目标为每天负≥0.5 升)的急性肾损伤(AKI)的危重症成年患者的队列研究。液体管理参数包括:1)净超滤率(NUF);2)FBGoal;3)FBAchieved;4)%FBGap(实现的液体平衡与目标之间的差距),均根据患者的体重(kg)和 CRRT 的持续时间(小时)进行调整。

结果

对 653 例患者(CRRT 中位数为 102.2 个患者小时)的数据进行了分析。平均(SD)年龄为 56.7(14.6)岁,61.9%为男性。住院死亡率为 64%。尽管死亡患者与存活患者的 FBGoal 相似,但存活患者在 CRRT 期间实现了更大的负液体平衡:中位数 FBAchieved -0.25[-0.52 至-0.05]与 0.06[-0.26 至 0.62]ml/kg/h,p<0.001。死亡患者的 NUF 中位数低于存活患者:1.06[0.63-1.47]与 1.22[0.82-1.69]ml/kg/h,p<0.001,死亡患者的中位数%FBGap 更高(112.8%,61.5%至 165.7%)与存活患者(64.2%,30.5%至 91.8%)相比,p<0.001。在多变量模型中,较高的%FBGap 与住院死亡率增加独立相关:比值比(95%CI)1.01(1.01-1.02),p<0.001。当通过%FBGap 和其他临床参数调整时,NUF 与住院死亡率无关:比值比 0.96(0.72-1.28),p=0.771。

结论

在接受 CRRT 的 AKI 危重症成人中,较高的%FBGap 与通过 CRRT 规定负液体平衡的临床医生的住院死亡率增加独立相关。%FBGap 是 CRRT 实施的一种新的质量指标,可协助在 CRRT 期间实施液体管理干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/0b601d3e0db0/pone.0272913.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/0e51782eb435/pone.0272913.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/a5e3c33a6f8c/pone.0272913.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/cdfb6cc2b63d/pone.0272913.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/c1e08963283e/pone.0272913.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/cfdf410a7e78/pone.0272913.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/0b601d3e0db0/pone.0272913.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/0e51782eb435/pone.0272913.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/a5e3c33a6f8c/pone.0272913.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/cdfb6cc2b63d/pone.0272913.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/c1e08963283e/pone.0272913.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/cfdf410a7e78/pone.0272913.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29ba/9409548/0b601d3e0db0/pone.0272913.g006.jpg

相似文献

1
Assessment of prescribed vs. achieved fluid balance during continuous renal replacement therapy and mortality outcome.评估连续性肾脏替代治疗期间规定的与实现的液体平衡与死亡率结局。
PLoS One. 2022 Aug 25;17(8):e0272913. doi: 10.1371/journal.pone.0272913. eCollection 2022.
2
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study.连续肾脏替代治疗的危重症患者中,液体清除与更好的结局相关:一项队列研究。
Crit Care. 2020 Jun 1;24(1):279. doi: 10.1186/s13054-020-02986-4.
3
Current Fluid Management Practice in Critically Ill Adults on Continuous Renal Replacement Therapy: A Binational, Observational Study.目前连续肾脏替代治疗成人患者的液体管理实践:一项跨国、观察性研究。
Blood Purif. 2024;53(8):624-633. doi: 10.1159/000538421. Epub 2024 Apr 16.
4
Early fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy.早期液体管理影响终末期肾病行慢性血液透析且需要持续肾脏替代治疗患者的短期死亡率。
BMC Nephrol. 2022 Mar 14;23(1):102. doi: 10.1186/s12882-022-02725-7.
5
Fluid Management during Continuous Renal Replacement Therapy: A Case-Based Approach.连续性肾脏替代治疗中的液体管理:基于病例的方法
Nephron. 2023;147(12):782-787. doi: 10.1159/000534395. Epub 2023 Oct 4.
6
The interaction of net ultrafiltration rate with urine output and fluid balance after continuous renal replacement therapy initiation: A multi-Centre study.启动连续肾脏替代治疗后净超滤率与尿量和液体平衡的相互作用:一项多中心研究。
J Crit Care. 2024 Oct;83:154835. doi: 10.1016/j.jcrc.2024.154835. Epub 2024 May 20.
7
Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial.网络超滤率与接受连续性静脉-静脉血液滤过治疗的急性肾损伤危重症成人死亡率的相关性:肾脏替代治疗随机评估正常 vs 增强水平(RENAL)试验的二次分析。
JAMA Netw Open. 2019 Jun 5;2(6):e195418. doi: 10.1001/jamanetworkopen.2019.5418.
8
Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy: a multicenter retrospective cohort study.需要持续肾脏替代治疗的接受体外膜肺氧合的儿科患者的液体超负荷与液体清除:一项多中心回顾性队列研究
Pediatr Nephrol. 2020 May;35(5):871-882. doi: 10.1007/s00467-019-04468-4. Epub 2020 Jan 17.
9
Initial renal replacement therapy (RRT) modality associates with 90-day postdischarge RRT dependence in critically ill AKI survivors.初始肾脏替代治疗(RRT)方式与危重症急性肾损伤(AKI)幸存者出院后90天的RRT依赖相关。
J Crit Care. 2024 Aug;82:154764. doi: 10.1016/j.jcrc.2024.154764. Epub 2024 Mar 8.
10
Early restrictive fluid balance is associated with lower hospital mortality independent of acute disease severity in critically ill patients on CRRT.在接受 CRRT 的危重症患者中,早期限制液体平衡与急性疾病严重程度无关,与较低的住院死亡率相关。
Sci Rep. 2021 Sep 14;11(1):18216. doi: 10.1038/s41598-021-97888-y.

引用本文的文献

1
Trajectories of fluid management after the initiation of renal replacement therapy in critically ill patients: a secondary analysis of the STARRT-AKI trial.危重症患者开始肾脏替代治疗后的液体管理轨迹:STARRT-AKI试验的二次分析
Crit Care. 2025 May 27;29(1):216. doi: 10.1186/s13054-025-05447-y.
2
Achievement of fluid removal targets during intermittent renal replacement therapy in the intensive care unit.重症监护病房中间歇性肾脏替代治疗期间液体清除目标的达成。
Clin Kidney J. 2024 Aug 20;17(9):sfae257. doi: 10.1093/ckj/sfae257. eCollection 2024 Sep.
3
Association of continuous renal replacement therapy downtime with fluid balance gap and clinical outcomes: a retrospective cohort analysis utilizing EHR and machine data.

本文引用的文献

1
How To Prescribe And Troubleshoot Continuous Renal Replacement Therapy: A Case-Based Review.如何开具和解决连续肾脏替代治疗处方:基于案例的复习。
Kidney360. 2020 Dec 14;2(2):371-384. doi: 10.34067/KID.0004912020. eCollection 2021 Feb 25.
2
Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.危重症患者连续性肾脏替代治疗剂量:一个名副其实的质量指标。
Nephron. 2021;145(2):91-98. doi: 10.1159/000512846. Epub 2021 Feb 4.
3
Continuous Renal Replacement Therapy: The Interaction between Fluid Balance and Net Ultrafiltration.
持续肾脏替代治疗停机时间与液体平衡差距及临床结局的关联:一项利用电子健康记录和机器数据的回顾性队列分析
J Intensive Care. 2024 Dec 31;12(1):55. doi: 10.1186/s40560-024-00772-w.
4
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach.连续性肾脏替代治疗中的精准净超滤剂量:一种实用方法
Intensive Care Med Exp. 2023 Nov 28;11(1):83. doi: 10.1186/s40635-023-00566-8.
连续性肾脏替代治疗:液体平衡与净超滤之间的相互作用
Am J Respir Crit Care Med. 2021 May 1;203(9):1199-1201. doi: 10.1164/rccm.202011-4097LE.
4
Net ultrafiltration prescription survey in Europe.欧洲网络超滤处方调查。
BMC Nephrol. 2020 Dec 1;21(1):522. doi: 10.1186/s12882-020-02184-y.
5
Development, implementation and outcomes of a quality assurance system for the provision of continuous renal replacement therapy in the intensive care unit.重症监护病房连续性肾脏替代治疗质量保证体系的建立、实施和效果评价。
Sci Rep. 2020 Nov 26;10(1):20616. doi: 10.1038/s41598-020-76785-w.
6
Mediators of the Impact of Hourly Net Ultrafiltration Rate on Mortality in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.小时净超滤率对连续性肾脏替代治疗危重症患者死亡率影响的中介因素。
Crit Care Med. 2020 Oct;48(10):e934-e942. doi: 10.1097/CCM.0000000000004508.
7
Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study.连续肾脏替代治疗的危重症患者中,液体清除与更好的结局相关:一项队列研究。
Crit Care. 2020 Jun 1;24(1):279. doi: 10.1186/s13054-020-02986-4.
8
Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy.接受连续性肾脏替代治疗的危重症患者的早期净超滤率与死亡率
Nephrol Dial Transplant. 2021 May 27;36(6):1112-1119. doi: 10.1093/ndt/gfaa032.
9
Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy: A Multinational Survey of Critical Care Practitioners.接受肾脏替代治疗的危重症患者的网络超滤液处方和实践:危重病护理从业者的跨国调查。
Crit Care Med. 2020 Feb;48(2):e87-e97. doi: 10.1097/CCM.0000000000004092.
10
The utility of point-of-care ultrasound in the assessment of volume status in acute and critically ill patients.床旁超声在评估急性和危重症患者容量状态中的应用。
World J Emerg Med. 2019;10(4):232-238. doi: 10.5847/wjem.j.1920-8642.2019.04.007.